Frequency of Vancomycin Target Trough Attainment for Cutaneous and Invasive Staphylococcal Infections

被引：0
|
作者：
Linakis, M. W. [1 ]
Constance, J. E. [1 ]
Stockmann, C. [1 ]
Campbell, S. C. [1 ]
Sherwin, C. M. T. [1 ]
Spigarelli, M. G. [1 ]
机构：
[1] Univ Utah, Div Clin Pharmacol, Dept Pediat, Salt Lake City, UT 84112 USA
来源：
THERAPEUTIC DRUG MONITORING | 2013年 / 35卷 / 05期
关键词：
vancomycin; trough; cellulitis; MRSA;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：697 / 697
页数：1
相关论文
共 50 条
  • [41] VANCOMYCIN THERAPY FOR SERIOUS STAPHYLOCOCCAL INFECTIONS IN CHRONIC-HEMODIALYSIS PATIENTS
    BIERMAN, MH
    NEEDHAMWALKER, CA
    HAMMEKE, M
    EGAN, JD
    JOURNAL OF DIALYSIS, 1980, 4 (04): : 179 - 184
  • [42] VANCOMYCIN AND NEUTROPENIA IN AZT-TREATED AIDS PATIENTS WITH STAPHYLOCOCCAL INFECTIONS
    KITCHEN, LW
    CLARK, RA
    HANNA, BJ
    POLLOCK, B
    VALAINIS, GT
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1990, 3 (09) : 925 - 926
  • [43] THERAPY OF STAPHYLOCOCCAL INFECTIONS WITH CEFAMANDOLE OR VANCOMYCIN ALONE OR WITH A COMBINATION OF CEFAMANDOLE AND TOBRAMYCIN
    COPPENS, L
    HANSON, B
    KLASTERSKY, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) : 36 - 41
  • [44] Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept
    Cojutti, Pier Giorgio
    Rinaldi, Matteo
    Gatti, Milo
    Tedeschi, Sara
    Viale, Pierluigi
    Pea, Federico
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (05)
  • [45] Optimization of time to initial vancomycin target trough improves clinical outcomes
    Cardile, Anthony P.
    Tan, Christopher
    Lustik, Michael B.
    Stratton, Amy N.
    Madar, Cristian S.
    Elegino, Jun
    Hsue, Guenther
    SPRINGERPLUS, 2015, 4
  • [46] Atopic Dermatitis in Patients with Agammaglobulinemia Is Associated with Cutaneous Staphylococcal Infections
    Damrongwatanasuk, Rongras
    Sriaroon, Panida
    Sleasman, John
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB73 - AB73
  • [47] Vancomycin therapy in secondary care; investigating factors that impact therapeutic target attainment
    Rawson, Timothy M.
    Charani, Esmita
    Moore, Luke S. P.
    Herrero, Pau
    Baik, Ji Soo
    Philip, Akash
    Gilchrist, Mark
    Brannigan, Eimear T.
    Georgiou, Pantelis
    Hope, William
    Holmes, Alison H.
    JOURNAL OF INFECTION, 2017, 74 (03) : 320 - 324
  • [48] Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support
    Cies, Jeffrey J.
    Moore, Wayne S., II
    Nichols, Kristen
    Knoderer, Chad A.
    Carella, Dominick M.
    Chopra, Arun
    PEDIATRIC CRITICAL CARE MEDICINE, 2017, 18 (10) : 977 - 985
  • [49] Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses
    Orsini, JA
    Snooks-Parsons, C
    Stine, L
    Haddock, M
    Ramberg, CE
    Benson, CE
    Nunamaker, DM
    CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2005, 69 (04): : 278 - 286
  • [50] SHOULD HIGHER VANCOMYCIN TROUGH LEVELS BE TARGETED FOR INVASIVE COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS IN CHILDREN?
    Jimenez-Truque, Natalia
    Thomsen, Isaac
    Saye, Elizabeth
    Creech, C. Buddy
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (04) : 368 - 370
12345